Stock Taper
SCREENER COMPARE ANY 2 STOCKS
NERV
MINERVA NEUROSCIENCES, INC.
NASDAQ
$4.84
▼ DOWN 5.65% (-0.29)

KEY STATISTICS

Market Cap$225.49 M
52w High$12.46
52w Low$1.93
Dividend Yield—
Frequency—
P/E-1.13
Volume135.73K
Shares Out.46.59M

COMPANY

LEADERSHIP

Remy Luthringer
CHIEF EXECUTIVE
Remy Luthringer

COMPENSATION 2026

Salary$675,027
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$6,513
Total$9,354,184

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 1, 2014
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
7

PRICE TARGET

Target High$10.00
Target Low$10.00
Target Median$10.00
Target Consensus$10.00

UPCOMING EARNINGS

DateNov 4, 2026
DayWednesday
Rev. Est.—
NOV
4
WED

SPLIT RECORD

DATETYPERATIO
2022-06-21Reverse1:8

PRICE

$4.84 ▼ DOWN 5.65% (−$0.29)
OVERLAYS
$4.80$4.95$5.10$5.259:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM4.84

About Minerva Neurosciences, Inc.

https://www.minervaneurosciences.com ↗

Minerva Neurosciences, a Waltham-based clinical-stage biopharma, develops CNS disorder treatments like roluperidone for schizophrenia and MIN-301 for neurodegenerative diseases, with a global license agreement with Mitsubishi Tanabe Pharma.

INDUSTRY

Biotechnology

A PRODUCT MINERVA NEUROSCIENCES, INC. IS KNOWN FOR

Roluperidone (MIN-101)
Roluperidone (MIN-101)

Roluperidone, Minerva Neurosciences' lead investigational drug, targets negative schizophrenia symptoms by selectively blocking serotonin, sigma, and adrenergic receptors without directly affecting dopamine.

COMPETITORS

COMPETITOR
ACAD COMPARE
ALKS COMPARE
NBIX COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
44
LISTED HERE
6
RANKED BY POSITION SIZE
VTI
0.00% · 1.3M
XSU.TO
0.00% · 643.0K
XRS2.DE
0.01% · 31.1K
QQQS
0.51% · 22.8K
RSSL
0.01% · 16.1K
URTY
0.00% · 1.4K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
70.21%
HOLDERS
48
TOP 12 OF 48 · RANKED BY POSITION SIZE
Federated Hermes, Inc.
5.4M sh · $19.46M
Vivo Capital, LLC
4.3M sh · $26.04M
Janus Henderson Group Plc
4.3M sh · $25.87M
Balyasny Asset Management L.P.
4.3M sh · $25.66M
Logos Global Management LP
3.3M sh · $13.31M
Adage Capital Partners Gp, L.L.C.
2.8M sh · $11.41M
Farallon Capital Management LLC
2.4M sh · $14.25M
Foresite Capital Management Vi LLC
2.0M sh · $11.97M
Ally Bridge Group (Ny) LLC
1.7M sh · $9.97M
Dv Trading LLC
889.3K sh · $5.36M
Acuta Capital Partners, LLC
709.5K sh · $2.85M
Millennium Management LLC
708.3K sh · $4.27M

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
OFFICER: CHIEF OPERATING OFFICER
Reilly Joseph H.
— · 10.6K shares
2026-08-10
★
OFFICER: CHIEF OPERATING OFFICER
Reilly Joseph H.
— · 680.0K shares
2026-08-10
★
OFFICER: CHIEF ACCOUNTING OFFICER
Aliquo Anthony
— · 300.0K shares
2026-08-10
★
OFFICER: CHIEF OPERATING OFFICER
Reilly Joseph H.
— · 22.5K shares
2026-08-10

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
NEUTRAL 1
2 GRADES IN THE LAST 12 MONTHS
Jefferies BUY HC Wainwright & Co. NEUTRAL

SECTORS PEERS

PEERPRICE
RLYB$16.81COMPARE
NRXS$6.00COMPARE
TAOX$3.89COMPARE
ENLV$1.35COMPARE
NRSN$0.42COMPARE
XCUR$1.29COMPARE
CVKD$1.54COMPARE
CLGN$0.36COMPARE